On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 01/21/21
- Sierra Wireless CEO Thexton to retire
- 11/18/20
- Sierra Wireless completes divestiture of automotive embedded module product line
- 07/23/20
- Sierra Wireless to divest automotive embedded product line for $165M
- 01/21/21
- Seagate says 2020 'a very challenging year'
- 01/19/21
- Nidec files patent infringement suit against Seagate
- 12/28/20
- Seagate appoints Prat Bhatt to Board of Directors
- 12/16/20
- Intel announces next generation of memory and storage products
- 01/05/21
- HoldCo expresses concerns regarding Boston Private Financial, SVB Financial deal
- 01/04/21
- SVB Financial to acquire Boston Private Financial in $900M cash and stock deal
- 12/08/20
- Clearbanc, Silicon Valley Bank partner on new capital program
- 11/30/20
- SVB Financial to acquire WestRiver Group's debt investment business
- $143.94 /
-0.635 (-0.44%) - 01/21/21
- PPG says demand continues to improve in many of its end-use markets
- 01/11/21
- PPG appoints Bhaskar Ramachandran as CIO
- 01/11/21
- PPG reaches definitive agreement to acquire Worwag
- 01/08/21
- PPG to acquire VersaFlex Family of Companies
- 01/05/21
- Precigen announces FDA clearance of IND application for PRGN-2012
- 12/07/20
- Precigen: PRGN-3006 safe, well-tolerated to date
- 11/16/20
- Precigen announces dosing of first patients in ongoing PRGN-3005, -3006 trials
- 10/15/20
- Precigen's UltraPorator system receives FDA clearance
- 01/04/21
- Bank OZK increases quarterly cash dividend to 27.75c per share
- 10/08/20
- Bank OZK reports resignation of Chief Credit Officer of the bank
- 10/01/20
- Bank OZK raises quarterly dividend to 27.5c per share
- 01/21/21
- MediciNova rises 14% after disclosing activist stake by 3D Investment Partners
- 12/29/20
- MediciNova receives notice of allowance for patent covering MN-166
- 12/15/20
- MediciNova to be added to Nasdaq Biotechnology Index at open on 12/21
- 11/25/20
- MediciNova's MN-166 shows retinal thinning attenuation in Phase 2b trial
- 01/21/21
- Intuitive Surgical says overall procedure growth was 6% in Q4
- 10/27/20
- Intuitive Surgical launches $100M venture capital fund
- 10/15/20
- Intuitive Surgical slides 2.8% to $720 per share after Q3 results
- 10/15/20
- Intuitive Surgical's first 9 months of 2020 saw 'significant impact' from COVID
- 01/21/21
- IBM down 6.5% at $123.24 after Q4 earnings, conference call outlook
- 01/21/21
- IBM sees FY21 'revenue growth based on current spot rates'
- 01/21/21
- IBM NewCo CEO Martin Schroeter says company has 'tremendous potential'
- 01/21/21
- IBM CFO says optimizing NewCo to have a 'leaner' operating model
- 01/21/21
- Fluidigm gets CE-IVD mark for its saliva-based Advanta assay for Covid
- 01/05/21
- Fluidigm announces publication on potential for Imaging Mass Cytometry
- 11/24/20
- Fluidigm says India CDSCO grants commercial license for Advanta Dx Assay
- 11/19/20
- Fluidigm announces results of study using Imaging Mass Cytometry
- 01/21/21
- Ford sees 2020 underfunded status for pension of about $6.7B
- 01/21/21
- Ford to replace Takata airbag inflators in certain models at cost of $610M
- 01/19/21
- EU passenger car registrations down 3.3% in December
- 01/11/21
- Ford to stop manufacturing in Brazil, sees pre-tax special item charges of $4.1B
- $91.61 /
-1.6101 (-1.73%) - 01/20/21
- North American rail traffic rose 8.6% in the week ended January 16
- 01/14/21
- North American rail traffic rose 3% in the week ended January 9
- 01/07/21
- North American rail traffic rose 1.3% in the week ended January 2
- 12/31/20
- North American rail traffic rose 7% in week ended December 26
- 01/21/21
- Amarin announces CSC included icosapent ethyl in CD prevention guidelines
- 01/07/21
- Amarin provides outlook on 2021 cash & expenses
- 12/14/20
- Amarin says Vascepa reduced Covid inflammation by 25% in early study
- 12/14/20
- Amarin announces presentation of Vascepa findings at conference
- 01/21/21
- Aldeyra rises 6% after 1.37M share purchase disclosed by Perceptive Advisors
- 01/07/21
- Aldeyra announces top-line results from run-in cohort in Tranquility study
- 12/22/20
- Aldeyra confirms SARS-CoV-2 antiviral activity of ADX-1612
- 12/17/20
- Aldeyra initiates Phase 2 trials of ADX-629
- 01/14/21
- Aurora Cannabis announces Canadian retail sales deal with Great North
- 01/06/21
- Aurora Cannabis rises 13.7%
- 01/06/21
- Aurora Cannabis rises 13.8%
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
- 01/08/21 Oppenheimer
- Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move'
- 01/05/21 DA Davidson
- SVB Financial price target raised to $400 from $365 at DA Davidson
- 01/05/21 Raymond James
- SVB Financial price target raised to $440 from $325 at Raymond James
- 01/05/21 RBC Capital
- SVB Financial price target raised to $437 from $320 at RBC Capital
- 01/08/21 UBS
- Western Alliance upgraded to Buy from Neutral at UBS
- 01/04/21 Stephens
- Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
- 12/15/20 Truist
- Truist raises price targets on select regional banks
- 11/04/20 Stephens
- Western Alliance resumed with an Overweight at Stephens
- 12/17/20 Seaport Global
- Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys
- 12/17/20 Seaport Global
- Independent Bank initiated with a Neutral at Seaport Global
- 10/26/20 Compass Point
- Independent Bank upgraded to Buy from Neutral at Compass Point
- 06/24/20 Piper Sandler
- Independent Bank downgraded to Neutral from Overweight at Piper Sandler
- 06/17/20 Raymond James
- Bank OZK upgraded to Outperform from Market Perform at Raymond James
- 06/17/20 Citi
- Bank OZK downgraded to Neutral from Buy at Citi
- 06/17/20 Raymond James
- Bank OZK upgraded to Outperform from Market Perform at Raymond James
- 04/28/20 Truist
- Bank OZK price target raised to $22 from $19 at SunTrust
- 12/17/20 BTIG
- Illumina upgraded to Buy from Neutral at BTIG
- 11/09/20 Piper Sandler
- Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
- 10/19/20 Piper Sandler
- Fluidigm test pact in Texas 'another validation,' says Piper Sandler
- 09/29/20 Piper Sandler
- Piper Sandler would be buyers of Fluidigm given recent pullback
- 01/14/21
- Fly Intel: Top five analyst initiations
- 01/14/21 B. Riley Securities
- Sierra Wireless initiated with a Buy at B. Riley Securities
- 11/25/20 Colliers
- Sierra Wireless initiated with a Buy at Colliers
- 02/14/20 Roth Capital
- Roth Capital sees upside in Sierra Wireless after 2020 transition year
- 01/08/21 Jefferies
- Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
- 01/08/21 Citi
- Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
- 01/07/21 Alliance Global Partners
- Aldeyra in an 'enviable position' after Phase 3 Tranquility data, says AGP
- 12/16/20 Berenberg
- Berenberg starts Aldeyra with Buy, sees near-term catalysts
- 01/08/21 Piper Sandler
- Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target
- 12/28/20 Cantor Fitzgerald
- Vascepa showing positive year-over-year trends, says Cantor Fitzgerald
- 12/23/20 Goldman Sachs
- Amarin price target lowered to $6 from $8 at Goldman Sachs
- 12/14/20 Piper Sandler
- Amarin's Vascepa showed 'encouraging results' in Covid patients, says Piper
- 10/20/20 Morgan Stanley
- Morgan Stanley continues to view IBM as 'a 2022 stock'
- 10/20/20 Citi
- IBM is 'getting even more complex,' says Citi
- 10/20/20 BMO Capital
- IBM price target lowered to $138 from $140 at BMO Capital
- 10/09/20 Morgan Stanley
- IBM price target raised to $140 from $128 at Morgan Stanley
- 01/21/21 Barclays
- Seagate price target raised to $60 from $41 at Barclays
- 01/20/21 Wedbush
- Seagate price target raised to $56 from $47 at Wedbush
- 01/19/21 Northland
- Seagate price target raised to $72 from $65 at Northland
- 01/19/21 Loop Capital
- Seagate price target raised to $70 from $60 at Loop Capital
- $143.94 /
-0.635 (-0.44%) - 01/20/21 Citi
- Citi adds PPG to US Focus List, removes FMC
- 01/14/21 Berenberg
- PPG upgraded to Buy with $165 price target at Berenberg
- 01/14/21 Berenberg
- PPG upgraded to Buy from Hold at Berenberg
- 12/01/20 Deutsche Bank
- PPG price target raised to $165 from $155 at Deutsche Bank
- 12/15/20 Morgan Stanley
- Intuitive Surgical downgraded to Equal Weight on valuation at Morgan Stanley
- 12/15/20 Morgan Stanley
- Intuitive Surgical downgraded to Equal Weight from Overweight at Morgan Stanley
- 11/24/20 Raymond James
- Intuitive Surgical not surprised by J&J robot features, says Raymond James
- 10/16/20 JPMorgan
- Intuitive Surgical price target raised to $785 from $765 at JPMorgan
- $91.61 /
-1.6101 (-1.73%) - 01/20/21 Susquehanna
- Railroad recovery expected to continue in 2021, says Susquehanna
- 01/11/21 Citi
- CSX price target raised to $105 from $87 at Citi
- 12/10/20 Morgan Stanley
- Morgan Stanley downgrades CSX to Underweight with bar raised too high
- 12/10/20 Morgan Stanley
- CSX downgraded to Underweight from Equal Weight at Morgan Stanley
- 12/16/20 H.C. Wainwright
- Precigen price target raised to $10 from $8 at H.C. Wainwright
- 05/08/20
- Fly Intel: Top analyst initiations
- 05/08/20 H.C. Wainwright
- Precigen initiated with a Buy at H.C. Wainwright
- 01/06/21 BMO Capital
- Federal cannabis reform in U.S. likely to take time, says BMO Capital
- 12/17/20 BMO Capital
- Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 01/20/21 Deutsche Bank
- Ford price target raised to $11 from $9 at Deutsche Bank
- 01/20/21 Deutsche Bank
- Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank
- 01/05/21 Benchmark
- GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
- 12/23/20 Morgan Stanley
- Apple's potential EV entry represents 'new Tesla bear case,' says Morgan Stanley
- 01/21/21
- Western Alliance reports Q4 EPS $1.93 , consensus $1.32
- 10/22/20
- Western Alliance reports Q3 EPS $1.36, consensus $1.04
- 01/21/21
- Sierra Wireless sees Q4 revenue above street consensus of $116.5M
- 11/12/20
- Sierra Wireless cannot estimate COVID-19 impact on Q4 and beyond
- 11/12/20
- Sierra Wireless reports Q3 EPS (19c), consensus (15c)
- 08/06/20
- Sierra Wireless reports Q2 non-GAAP EPS (30c), consensus (35c)
- 01/21/21
- Seagate sees Q3 adjusted EPS $1.30, plus/minus 15c, consensus $1.26
- 01/21/21
- Seagate reports Q2 adjusted EPS $1.29, consensus $1.13
- 10/22/20
- Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08
- 10/22/20
- Seagate reports Q1 adjusted EPS 93c, consensus 88c
- 01/21/21
- SVB Financial reports Q4 EPS $7.40, consensus $3.83
- 10/23/20
- SVB Financial reports Q3 EPS $8.47, consensus $5.14
- 07/23/20
- SVB Financial reports Q2 EPS $4.42, consensus $3.11
- $143.94 /
-0.635 (-0.44%) - 01/21/21
- PPG reports Q4 EPS $1.59, consensus $1.58
- 10/19/20
- PPG sees Q4 adjusted EPS $1.50-$1.57, consensus $1.44
- 10/19/20
- PPG reports Q3 adjusted EPS $1.93, consensus $1.92
- 11/09/20
- Precigen reports Q3 EPS (18c), consensus (14c)
- 08/10/20
- Precigen reports Q2 EPS (26c), consensus (13c)
- 01/21/21
- Bank OZK reports Q4 EPS 93c, consensus 78c
- 10/22/20
- Bank OZK reports Q3 EPS 84c, consensus 58c
- 07/23/20
- Bank OZK reports Q2 EPS 39c, consensus 33c
- 01/21/21
- Intuitive Surgical reports Q4 EPS $3.58, consensus $3.12
- 01/13/21
- Intuitive Surgical sees 2020 revenue $4.36B, consensus $4.27B
- 01/13/21
- Intuitive Surgical sees Q4 revenue $1.33B, consensus $1.23B
- 01/21/21
- Independent Bank reports Q4 EPS $1.05, consensus $1.03
- 10/22/20
- Independent Bank reports Q3 adjusted EPS $1.07, consensus 81c
- 07/23/20
- Independent Bank Corp. reports Q2 EPS 76c, consensus 62c
- 01/21/21
- IBM reports Q4 Cloud & Cognitive Software revenue $6.8B, down 4.5%
- 01/21/21
- IBM reports Q4 adjusted EPS $2.07, consensus $1.79
- 01/21/21
- Notable companies reporting after market close
- 10/19/20
- IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7%
- 11/05/20
- Fluidigm reports Q3 EPS 3c, consensus (20c)
- 08/06/20
- Fluidigm reports Q2 EPS (18c), consensus (23c)
- 10/28/20
- Ford sees temporarily lower F-150 wholesale shipments in Q4
- 10/28/20
- Ford reports Q3 adjusted EBIT $3.6B
- 10/28/20
- Ford reports Q3 adjusted EPS 65c, consensus 16c
- 10/28/20
- Notable companies reporting after market close
- $91.61 /
-1.6101 (-1.73%) - 01/21/21
- CSX reports Q4 EPS 99c, consensus $1.00
- 10/21/20
- CSX reports Q3 EPS 96c, consensus 92c
- 10/21/20
- Notable companies reporting after market close
- 01/07/21
- Amarin sees FY20 revenue up 42% to $610M, consensus $619.19M
- 11/05/20
- Amarin reports Q3 non-GAAP EPS (1c), consensus 1c
- 08/04/20
- Amarin reports Q2 adjusted EPS 4c, consensus (7c)
- 11/05/20
- Aldeyra reports Q3 EPS (23c), consensus (27c)
- 08/06/20
- Aldeyra reports Q2 EPS (25c), consensus (34c)
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
|
On The Fly
| ShowHide Related Items >><< - 12/17/20
- Zynerba announces development plan for Zygel
- 12/17/20
- Zynerba provides regulatory update on Zygel in Fragile X syndrome
- 12/10/20
- Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer
- 01/14/21
- Aphria CEO says 'we are pleased with our second quarter results'
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 12/15/20
- Tilray up 8%, Aphria up 2% after merger speculation reported by Bloomberg
IGC India Globalization Capital - 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 08/11/20
- India Globalization gets FDA approval to initiate cannabinoid formulation study
- 01/05/21
- CV Sciences launches ProCBD product line
- 12/08/20
- CV Sciences enters common stock purchase agreement with Tumim Stone
- 11/04/20
- CV Sciences launches PlusCBD pet product line
- 01/08/21
- CannTrust launches new medical brand, estora
- 12/02/20
- CannTrust returns to Canadian marketplace with two recreational brands
- 08/06/20
- CannTrust says licenses reinstated for Vaughan Manufacturing Facility
- 10/05/20
- Cronos Group launches PEACE NATURALS brand in Israel
- 09/09/20
- Cronos Group appoints Kurt Schmidt as CEO
- 01/14/21
- Canopy Growth files early warning report regarding TerrAscend Corp.
- 01/07/21
- Constellation recognized $770M increase in fair value of Canopy investments
- 12/21/20
- Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement
- 12/21/20
- Canopy Growth announces plan of arrangement with Canopy Rivers
- 01/04/21
- General Cannabis raises over $2.9M of senior convertible promissory notes
- 09/14/20
- General Cannabis appoints Diane Jones as CFO
- 01/14/21
- Aphria jumps 6.5% to $10.65 after posting strong Q2 results
- 01/14/21
- Aurora Cannabis announces Canadian retail sales deal with Great North
- 01/06/21
- Aurora Cannabis rises 13.7%
- 01/06/21
- Aurora Cannabis rises 13.8%
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
IGC India Globalization Capital - 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
- 12/21/20 H.C. Wainwright
- Zynerba price target lowered to $9 from $12 at H.C. Wainwright
- 07/01/20 H.C. Wainwright
- Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
- 01/19/21 Needham
- Trulieve Cannabis price target raised to $60.50 from $36.25 at Needham
- 01/13/21 Canaccord
- Trulieve Cannabis price target raised to C$75 from C$60 at Canaccord
- 01/15/21 Alliance Global Partners
- Aphria price target raised to C$20 from C$12 at Alliance Global Partners
- 01/15/21 BMO Capital
- Aphria price target raised to C$15 from C$7 at BMO Capital
- 12/24/20 Raymond James
- Raymond James says Village Farms situated well for cannabis sector consolidation
- 12/17/20 Canaccord
- Aphria downgraded to Hold from Speculative Buy at Canaccord
- 01/06/21 BMO Capital
- Federal cannabis reform in U.S. likely to take time, says BMO Capital
- 11/16/20 Jefferies
- Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
- 01/05/21 Cantor Fitzgerald
- Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
- 12/28/20 JPMorgan
- Constellation Brands price target raised to $248 from $218 at JPMorgan
- 06/12/20 Cowen
- CV Sciences initiated with a Market Perform at Cowen
- 12/17/20 BMO Capital
- Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
- 01/19/21 Stifel
- Aphria price target raised to $15.50 from $9.80 at Stifel
- 01/15/21 CIBC
- Aphria price target raised to C$18 from C$12.50 at CIBC
- 11/09/20
- Zynerba reports Q3 EPS (31c), consensus (43c)
- 08/10/20
- Zynerba reports Q2 EPS (78c), consensus (45c)
- 11/09/20
- Tilray sees positive or break even adjusted EBITDA in Q4
- 11/09/20
- Tilray reports Q3 EPS (2c), consensus (21c)
- 08/10/20
- Tilray reports Q2 EPS (66c), consensus (27c)
- 11/17/20
- Trulieve Cannabis reports Q3 EPS 15c
IGC India Globalization Capital - 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 11/05/20
- Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago
- 08/06/20
- Cronos Group reports Q2 EPS (31c) vs. 16c last year
- 01/07/21
- Constellation Brands reports Q3 adjusted EPS ex. Canopy $3.16, consensus $2.39
- 11/09/20
- Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year
- 10/01/20
- Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91
- 01/14/21
- Aphria reports Q2 adjusted EPS C$0.01 vs. (C$0.19) a year ago
- 10/15/20
- Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
|